Symptom score, exercise capacity, and quality of life were significantly higher in the ablation group.

In this group, the therapeutic benefit of TOLAMBA in reducing total nasal symptom scores was evident, as reflected in a clinically meaningful reduction of TNSS in the treated patients.

Results The morbidity of hypertension, diabetes mellitus , atypical symptom MI, severe arrhythmia and shock were higher in senile group(P< 0.05).